Indian health activists criticise voluntary price cuts by drug industry.
作者信息
Mudur Ganapati
出版信息
BMJ. 2006 Nov 18;333(7577):1036. doi: 10.1136/bmj.39031.665868.DB.
Abstract
摘要
相似文献
1
Indian health activists criticise voluntary price cuts by drug industry.印度健康活动人士批评制药行业自愿降价行为。
BMJ. 2006 Nov 18;333(7577):1036. doi: 10.1136/bmj.39031.665868.DB.
2
Indian drug maker cuts price of three cancer drugs by between 50% and 63%.印度制药商将三种抗癌药物的价格降低了50%至63%。
BMJ. 2012 Nov 16;345:e7786. doi: 10.1136/bmj.e7786.
3
HMOs see drug price hikes double in wake of Medicaid 'best price' legislation--GAO.美国政府问责局称，在医疗补助“最优惠价格”立法出台后，健康维护组织（HMOs）发现药品价格涨幅翻倍。
Mod Healthc. 1993 Jan 18;23(3):2.
4
How market based pricing is failing Indian patients.基于市场的定价如何让印度患者失望。
BMJ. 2014 Jan 28;348:g278. doi: 10.1136/bmj.g278.
5
The development of a value based pricing index for new drugs in metastatic colorectal cancer.新型转移性结直肠癌药物基于价值的定价指数的制定。
Eur J Cancer. 2011 Jun;47(9):1299-304. doi: 10.1016/j.ejca.2011.03.015. Epub 2011 Apr 13.
6
[Drug industry in India is threatened by free trade agreement].[印度制药行业受到自由贸易协定的威胁]
Lakartidningen. 2009;106(41):2589.
7
Price controls in the pharmaceutical industry could hurt medical education.制药行业的价格管制可能会损害医学教育。
Nephrol News Issues. 1993 Jun;7(6):46-7.
8
Access to and price of medicines globally.全球药品的可及性与价格
Tidsskr Nor Laegeforen. 2011 Oct 18;131(20):2019-21. doi: 10.4045/tidsskr.11.0744.
9
The price of pills. Does it really take $897 million for a new therapy?药丸的价格。一种新疗法真的需要8.97亿美元吗？
Sci Am. 2003 Jul;289(1):25.
10
Drugmakers' price plan ruled to be price-fixing by agency.制药商的定价计划被监管机构裁定为价格垄断行为。
Mod Healthc. 1993 Oct 11;23(41):8.
Zotero 插件